-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The increased long-term use of opioids in patients with chronic non-cancerous pain (CNCP) may raise concerns about opioid-related behaviors.
These actions may include: non-medical use of opioids (including tampering with drugs), transfer of drugs to others, and the development of opioid dependence.
Pixabay.
Some researchers have used data from the pain and opioid treatment cohort (POINT cohort) to study this problem.
Some researchers have used data from the pain and opioid treatment cohort (POINT cohort) to study this problem.
This 5-year prospective cohort study included 1,514 adults who were treated with opioids prescribed by CNCP.
This 5-year prospective cohort study included 1,514 adults who were treated with opioids prescribed by CNCP.
Among the 1514 participants, 672 (44.
The distribution of the number of interviews for a series of opioid use indicators and non-medical use indicators was observed in the point cohort (estimated data)
The distribution of the number of interviews (estimated data) for a series of opioid use indicators and non-medical use indicators was observed in the spot cohort.The study examined the prevalence, incidence, stopping and duration of four opioid use behaviors, as well as three non-medical use and harm indicators.
This finding challenges the prevailing view that the risk of opioid-related behaviors is static-risk assessment at the beginning of opioid treatment can predict which patients will develop opioid use disorder, thereby providing ongoing Provide information on the management plan.
,,,CNCP,。,。,。,,,CNCP,。,。,。,,,CNCP,。,。,。,,,CNCP,。,。,。CNCP,。,。,。CNCP,。,。,。
:Degenhardt L, Hungerford P, Nielsen S, et al.
:Degenhardt L, Hungerford P, Nielsen S, et al.
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
JAMA Netw Open.
2021;4(4):e213059.
com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
3059:Degenhardt L, Hungerford P, Nielsen S, et al.
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
JAMA Netw Open.
2021;4(4):e213059.
com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
3059:Degenhardt L, Hungerford P, Nielsen S, et al.
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
JAMA Netw Open.
2021;4(4):e213059.
com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
3059Degenhardt L, Hungerford P, Nielsen S, et al.
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.
JAMA Netw Open.
2021;4(4):e213059.
com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
3059com/journals/jamanetworkopen/fullarticle/2778344" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
3059